Can I Transfer My Parent's Assets to Myself Using My Power of Attorney?
As the agent under a power of attorney for an elderly parent with progressive dementia, is it allowable to move any or all th...Read more
If you are among the more than 49 million Americans enrolled in Medicare Part D, you may feel overwhelmed by the costs of your prescription drugs from one year to the next. Proposed legislation currently awaiting review by the Senate could bring you some relief in the form of significant savings.
Steady increases in prescription drug costs over time has been a growing concern for many Americans who rely on medication. In fact, one in five seniors on Medicare report having skipped their medications due to cost, according to one recent survey. Meanwhile, individuals with such serious health conditions as hepatitis C or certain cancers, for instance, often depend on an array of brand-name, specialty drugs that can easily total thousands of dollars.
Provisions in the bill, known as the Inflation Reduction Act of 2022, would, in part, empower the federal government to negotiate costs for some of the most expensive prescription medications.
What will that mean for Medicare Part D beneficiaries? Here is a look at the potential benefits, should the bill pass:
In addition to the proposed reforms on Medicare drug pricing, the plan also includes provisions on climate change, corporate taxes, and energy. If the bill becomes law, negotiations on drug pricing would start in 2026. The potential savings you would experience would vary depending on the type of medications you take. Decisions have yet to be made regarding the specific prescription drugs for which prices would be negotiated. The Senate is expected to vote before the end of August 2022.